EN Mobile Logo

Search form



Cannabinoid Compounds for Type 2 Diabetes

There are claims, ranging from anecdotal reports to experimental research, that cannabis and its derivative compounds have medicinal use for diabetes.


© Slunculak/Shutterstock.com

Recent Content

In patients with type 2 diabetes complicated by nephropathy, what is the real life effect of statin therapy on cardiovascular disease prevention?

A roundup of insulin-related FDA news includes approved combination medications, the latest devices, and CT imaging recommendations for insulin pumps.

Do you hesitate to initiate insulin therapy in type 2 diabetes patients? To understand barriers, researchers conducted a cross-sectional survey.

With the holidays upon us, this month’s topic is a timely one – diet/physical activity misconceptions you may hear from patients and their families.

Two studies examined the effects of sugar-sweetened beverages on prediabetes and insulin resistance and of low-calorie beverages on weight loss.

SGLT2 inhibitors made diabetes headlines this year by gaining FDA approval for cardiovascular indication. We highlight this news and more for 2016.

A 68-year-old man with long-standing hypertension, ischemic heart disease, obesity, T2DM, & rheumatoid arthritis was treated with an SGLT2 inhibitor.

By clicking Accept, you agree to become a member of the UBM Medica Community.